Clinical Trial Update: A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase II trial of bicalutamide in patients receiving intravesical BCG for non-muscle invasive bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• bicalutamide (bicalutamide)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Non-Muscle Invasive Bladder Cancer | Phase 2 | Status: RECRUITING